- Home
- KNSA vs EXPI Comparison
KNSA vs EXPI Comparison
Compare KNSA & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- EXPI
- Stock Information
- Founded
- KNSA 2015
- EXPI 2008
- Country
- KNSA United Kingdom
- EXPI United States
- Employees
- KNSA N/A
- EXPI N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- EXPI Real Estate
- Sector
- KNSA Health Care
- EXPI Finance
- Exchange
- KNSA Nasdaq
- EXPI Nasdaq
- Market Cap
- KNSA 1.7B
- EXPI 2.0B
- IPO Year
- KNSA 2018
- EXPI N/A
- Fundamental
- Price
- KNSA $20.59
- EXPI $12.81
- Analyst Decision
- KNSA Strong Buy
- EXPI Hold
- Analyst Count
- KNSA 5
- EXPI 2
- Target Price
- KNSA $36.60
- EXPI $13.50
- AVG Volume (30 Days)
- KNSA 290.2K
- EXPI 1.3M
- Earning Date
- KNSA 10-29-2024
- EXPI 02-20-2025
- Dividend Yield
- KNSA N/A
- EXPI 1.56%
- EPS Growth
- KNSA N/A
- EXPI N/A
- EPS
- KNSA N/A
- EXPI N/A
- Revenue
- KNSA $384,098,000.00
- EXPI $4,458,228,000.00
- Revenue This Year
- KNSA $60.05
- EXPI $7.24
- Revenue Next Year
- KNSA $36.32
- EXPI $7.69
- P/E Ratio
- KNSA N/A
- EXPI N/A
- Revenue Growth
- KNSA 54.41
- EXPI 5.50
- 52 Week Low
- KNSA $16.56
- EXPI $8.91
- 52 Week High
- KNSA $28.15
- EXPI $16.48
- Technical
- Relative Strength Index (RSI)
- KNSA 40.95
- EXPI 47.15
- Support Level
- KNSA $19.97
- EXPI $12.49
- Resistance Level
- KNSA $20.85
- EXPI $13.07
- Average True Range (ATR)
- KNSA 0.69
- EXPI 0.67
- MACD
- KNSA 0.03
- EXPI -0.13
- Stochastic Oscillator
- KNSA 35.61
- EXPI 51.45
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.